APA (7th ed.) Citation

Ruiz‐Cobo, J. C., Llaneras, J., Forns, X., Gallego Moya, A., Conde Amiel, I., Arencibia, A., . . . Badia Aranda, E. (2024). Real‐life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir. Alimentary Pharmacology & Therapeutics, 60(2), 201. https://doi.org/10.1111/apt.18020

Chicago Style (17th ed.) Citation

Ruiz‐Cobo, Juan Carlos, et al. "Real‐life Effectiveness of Sofosbuvir/velpatasvir/voxilaprevir in Hepatitis C Patients Previously Treated with Sofosbuvir/velpatasvir or Glecaprevir/pibrentasvir." Alimentary Pharmacology & Therapeutics 60, no. 2 (2024): 201. https://doi.org/10.1111/apt.18020.

MLA (9th ed.) Citation

Ruiz‐Cobo, Juan Carlos, et al. "Real‐life Effectiveness of Sofosbuvir/velpatasvir/voxilaprevir in Hepatitis C Patients Previously Treated with Sofosbuvir/velpatasvir or Glecaprevir/pibrentasvir." Alimentary Pharmacology & Therapeutics, vol. 60, no. 2, 2024, p. 201, https://doi.org/10.1111/apt.18020.